Dr. Mirek Fatyga

Mayo Clinic, USA

Associate professor

Email: Fatyga.Mirek@mayo.edu

Qualifications

1986 Ph.D., Indiana University, USA

1981 M.Sc., University of Warsaw, Poland

Publications (Selected)

1. Feng H, Shan J, Ashman JB, Rule WG, Bhangoo RS, Yu NY, Chiang J, Fatyga M, Wong WW, Schild SE, Sio TT, Liu W. Technical Note: 4D robust optimization in small spot intensity-modulated proton therapy (IMPT) for distal esophageal carcinoma. Med Phys. 2021 May 31.
2. Yang Y, Vargas CE, Bhangoo RS, Wong WW, Schild SE, Daniels TB, Keole SR, Rwigema JM, Glass JL, Shen J, DeWees TA, Liu T, Bues M, Fatyga M, Liu W. Exploratory Investigation of Dose-Linear Energy Transfer (LET) Volume Histogram (DLVH) for Adverse Events Study in Intensity Modulated Proton Therapy (IMPT). Int J Radiat Oncol Biol Phys. 2021 Feb 20.
3. Craft DF, Lentz J, Armstrong M, Foster M, Gagneur J, Harrington D, Schild SE, Fatyga M. Three-Dimensionally Printed On-Skin Radiation Shields Using High-Density Filament. Pract Radiat Oncol. 2020 Nov - Dec; 10 (6):e543-e550, Epub 2020 May 13.
4. Shan J, Yang Y, Schild SE, Daniels TB, Wong WW, Fatyga M, Bues M, Sio TT, Liu W. Intensity-modulated proton therapy (IMPT) interplay effect evaluation of asymmetric breathing with simultaneous uncertainty considerations in patients with non-small cell lung cancer. Med Phys. 2020 Nov; 47 (11): 5428-5440, Epub 2020 Oct 13.
5. Feng H, Sio TT, Rule WG, Bhangoo RS, Lara P, Patrick CL, Korte S, Fatyga M, Wong WW, Schild SE, Ashman JB, Liu W. Beam angle comparison for distal esophageal carcinoma patients treated with intensity-modulated proton therapy. J Appl Clin Med Phys. 2020 Nov; 21 (11):141-152, Epub 2020 Oct 15.
6. Deng W, Younkin JE, Souris K, Huang S, Augustine K, Fatyga M, Ding X, Cohilis M, Bues M, Shan J, Stoker J, Lin L, Shen J, Liu W. Technical Note: Integrating an open source Monte Carlo code "MCsquare" for clinical use in intensity-modulated proton therapy. Med Phys. 2020 Jun; 47 (6):2558-2574, Epub 2020 Apr 13.
7. Liu X, Fatyga M, Schild SE, Li J. Detecting spatial susceptibility to cardiac toxicity of radiation therapy for lung cancer. IISE Trans Healthc Syst Eng. 2020; 10 (4):243-250, Epub 2020 July 22.
8. Kang Y, Shen J, Liu W, Taylor PA, Mehrens HS, Ding X, Hu Y, Tryggestad E, Keole SR, Schild SE, Wong WW, Fatyga M, Bues M. Impact of planned dose reporting methods on Gamma pass rates for IROC lung and liver motion phantoms treated with pencil beam scanning protons. Radiat Oncol. 2019 Jun 17; 14 (1):108, Epub 2019 June 17.
9. Liu X, Fatyga M, Wu T, Li J. Integration of biological and statistical models toward personalized radiation therapy of cancer Iise Transactions. 2019; 51(3):311-21, Epub 1900 Jan 01.
10. Hernandez Morales D, Shan J, Liu W, Augustine KE, Bues M, Davis MJ, Fatyga M, Johnson JE, Mundy DW, Shen J, Younkin JE, Stoker JB. Automation of routine elements for spot-scanning proton patient-specific quality assurance. Med Phys. 2019 Jan; 46 (1):5-14, Epub 2018 Nov 20.
11. Whitaker TJ, Mayo CS, Ma DJ, Haddock MG, Miller RC, Corbin KS, Neben-Wittich M, Leenstra JL, Laack NN, Fatyga M, Schild SE, Vargas CE, Tzou KS, Hadley AR, Buskirk SJ, Foote RL. Data collection of patient outcomes: one institution's experience. J Radiat Res. 2018 Mar 1; 59 (suppl_1):i19-i24.
12. Liu X, Li J, Schild SE, Li J, Schild MH, Wong W, Vora S, Herman MG, Fatyga M. Modeling of Acute Rectal Toxicity to Compare Two Patient Positioning Methods for Prostate Cancer Radiotherapy: Can Toxicity Modeling be Used for Quality Assurance? OMICS J Radiol. 2018; 7 (5) Epub 2018 Dec 03.
13. Liu X, Li J, Schild SE, Schild MH, Wong W, Vora S, Herman MG, Fatyga M. Statins and Metformin Use Is Associated with Lower PSA Levels in Prostate Cancer Patients Presenting for Radiation Therapy. J Cancer Ther. 2017 Feb; 8 (2):73-85 Epub 2017 Feb 06.
14. Mayo CS, Pisansky TM, Petersen IA, Yan ES, Davis BJ, Stafford SL, Garces YI, Miller RC, Martenson JA, Mutter RW, Choo R, Hallemeier CL, Laack NN, Ma DJ, Olivier KR, Keole SR, Fatyga M, Foote RL, Haddock MG. Establishment of practice standards in nomenclature and prescription to enable construction of software and databases for knowledge-based practice review. Pract Radiat Oncol. 2016 Jul-Aug; 6 (4): e117-e126, Epub 2016 Jan 26.
15. Liu X, Li J, Wu T, Schild SE, Schild MH, Wong W, Vora S, Fatyga M. Patient Specific Characteristics Are an Important Factor That Determines the Risk of Acute Grade >/= 2 Rectal Toxicity in Patients Treated for Prostate Cancer with IMRT and Daily Image Guidance Based on Implanted Gold Markers. OMICS J Radiol. 2016 Jun; 5 (3), Epub 2016 June 13.
16. Augustine KE, Walsh TJ, Beltran CJ, Stoker JB, Mundy DW, Parry MD, Bues M, Fatyga M. Spot scanning proton therapy plan assessment: Design and development of a dose verification application for use in routine clinical practice Progress in Biomedical Optics and Imaging - Proceedings of SPIE. 2016; 9783:97835S.
17. Liu W, Liao Z, Schild SE, Liu Z, Li H, Li Y, Park PC, Li X, Stoker J, Shen J, Keole S, Anand A, Fatyga M, Dong L, Sahoo N, Vora S, Wong W, Zhu XR, Bues M, Mohan R. Impact of respiratory motion on worst-case scenario optimized intensity modulated proton therapy for lung cancers. Pract Radiat Oncol. 2015 Mar-Apr; 5 (2):e77-86, Epub 2014 Sept 11.
18. Shen J, Liu W, Anand A, Stoker JB, Ding X, Fatyga M, Herman MG, Bues M. Impact of range shifter material on proton pencil beam spot characteristics. Med Phys. 2015 Mar; 42 (3): 1335-40.
19. Fatyga M, Dogan N, Weiss E, Sleeman WC IV, Zhang B, Lehman WJ, Williamson JF, Wijesooriya K, Christensen GE. A voxel-by-voxel comparison of deformable vector fields obtained by three deformable image registration algorithms applied to 4DCT lung studies. Frontiers in Oncology. 2015; 5(Feb): 17.
20. Weiss E, Fatyga M, Wu Y, Dogan N, Balik S, Sleeman W 4th, Hugo G. Dose escalation for locally advanced lung cancer using adaptive radiation therapy with simultaneous integrated volume-adapted boost. Int J Radiat Oncol Biol Phys. 2013 Jul 1; 86(3):414-9, Epub 2013 Mar 21.